Infant Botulism, Israel, 2007–2021
Bar Goldberg, Dana Danino, Yoel Levinsky, Itzhak Levy, Rachel Straussberg, Halima Dabaja-Younis, Alex Guri, Yotam Almagor, Diana Tasher, Daniel Elad, Zina Baider, Shlomo Blum, and Oded Scheuerman
Author affiliations: Schneider Children’s Medical Center, Petach Tikva, Israel (B. Goldberg, Y. Levinsky, I. Levy, R. Straussberg, O. Scheuerman); Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (B. Goldberg, I. Levy, R. Straussberg, D. Tasher, O. Scheuerman); Soroka Medical Center, Beer Sheva, Israel (D. Danino); Faculty of Health Sciences, Ben-Gurion University, Beer Sheva (D. Danino); Rambam Medical Center, Haifa, Israel (H. Dabaja-Younis); The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel (H. Dabaja-Younis); Kaplan Medical Center, Rehovot, Israel (A. Guri); Hadassah Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem (A. Guri); Meuhedet Healthcare, Jerusalem, Israel (Y. Almagor); Wolfson Medical Center, Holon, Israel (D. Tasher); National Reference Laboratory for Botulism, Kimron Veterinary Institute, Bet Dagan, Israel (D. Elad, Z. Baider, S. Blum)
Figure. Cases of infant botulism by 3-year period, Israel, 2007–2021. Numbers above bars indicate incidence for that period (no. cases/100,000 population).
Page created: December 01, 2022
Page updated: January 20, 2023
Page reviewed: January 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.